We are live on
!
Find out more
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
21 hedge funds and large institutions have $894K invested in Interpace Biosciences, Inc. Common Stock in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
25% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 4
11% more funds holding
Funds holding: 19 → 21 (+2)
51% less capital invested
Capital invested by funds: $1.84M → $894K (-$942K)
Holders
21
Holders Change
+2
Holders Change %
+10.53%
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
5
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VKH
Virtu KCG Holdings
New York
|
+$77.5K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$16.7K |
| 3 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$8.68K |
| 4 |
Renaissance Technologies
New York
|
+$6.55K |
| 5 |
Goldman Sachs
New York
|
+$1.13K |
Top Sellers
| 1 |
Dimensional Fund Advisors
Austin,
Texas
|
-$89.6K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.76K |
| 3 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$1.35K |
| 4 |
Bank of New York Mellon
New York
|
-$691 |
| 5 |
Morgan Stanley
New York
|
-$28 |
